LabGenius Therapeutics
LabGenius Therapeutics develops therapeutic antibodies using machine learning and automated laboratory screening. Its EVA discovery platform supports pharmaceutical partnerships and an internal pipeline targeting solid tumours.
Key facts
| Company Operating Status | Active |
|---|---|
| Full Address | Suite 1, 3rd Floor 11-12 St. James's Square LONDON , SW1Y 4LB United Kingdom |
| Wellfound ID | labgenius |
| Wikidata ID | Q56585160 |